Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

Read More

Kasuto advocates for energy conversations

Chairperson of the Economic Association of Namibia (EAN), Jason Kasuto said that if the oil and gas industry brings some promise, then Namibians should keep an open mind and not shy away from the energy conversation.Kasuto made these remarks on Tuesda…

Read More

Opuwo’s new CEO commences role

Matjandjara Tjihuura Katurota, the newly appointed Chief Executive Officer of Opuwo, began her duties on Tuesday following a special welcoming ceremony at the council chambers.Tjihuura Katurota took over from Petrus Shuuya, who had headed the council …

Read More

France, Italy to evacuate citizens from Niger

France will begin evacuating its citizens from Niger, which was taken over by the military in a coup, on Tuesday, the French Foreign Ministry said.It said it would also evacuate other Europeans who wanted to leave the country, a former French colony.A…

Read More